Considerations for the use and study of exogenous surfactant in respiratory disease from COVID-19
{{output}}
Exogenous surfactant therapy has been widely studied in acute respiratory distress syndrome (ARDS) but has failed to show mortality benefit in several trials. The COVID-19 pandemic has renewed interest in exogenous surfactant, and clinical trials are investiga... ...
